EPSTEIN-BARR VIRUS-POSITIVE T/NK-CELL LYMPHOPROLIFERATIVE DISEASE

Clinical trials for EPSTEIN-BARR VIRUS-POSITIVE T/NK-CELL LYMPHOPROLIFERATIVE DISEASE explained in plain language.

Never miss a new study

Get alerted when new EPSTEIN-BARR VIRUS-POSITIVE T/NK-CELL LYMPHOPROLIFERATIVE DISEASE trials appear

Sign up with your email to follow new studies for EPSTEIN-BARR VIRUS-POSITIVE T/NK-CELL LYMPHOPROLIFERATIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can tracking thousands of patients unlock the secrets of rare EBV-driven blood cancers?

Knowledge-focused Recruiting now

This study follows 1,500 people with Epstein-Barr virus-positive T/NK-cell lymphoproliferative diseases — rare conditions where the virus drives abnormal immune cell growth. Researchers will collect medical history, treatment details, and blood samples to see how the diseases beh…

Matched conditions: EPSTEIN-BARR VIRUS-POSITIVE T/NK-CELL LYMPHOPROLIFERATIVE DISEASE

Sponsor: Rong Tao • Aim: Knowledge-focused

Last updated Aug 15, 2026 00:00 UTC

EPSTEIN-BARR VIRUS-POSITIVE T/NK-CELL LYMPHOPROLIFERATIVE DISEASE

Get alerted when new EPSTEIN-BARR VIRUS-POSITIVE T/NK-CELL LYMPHOPROLIFERATIVE DISEASE trials appear

Can tracking thousands of patients unlock the secrets of rare EBV-driven blood cancers?